{"transactions":[{"id":832717,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:19:28.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":2.8,"value":280000.0,"ownership":{"direct":true},"balance_after":568000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001087294-26-000032","document":"wk-form4_1774041566.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000032/wk-form4_1774041566.xml","form_type":"4"}},{"id":835778,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-03-18T21:30:35.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":5845,"price":3.06,"value":17885.7,"ownership":{"direct":true},"balance_after":5695310,"source":{"system":"sec-edgar","filing":"0001628280-26-019514","document":"wk-form4_1773869429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828026019514/wk-form4_1773869429.xml","form_type":"4"}},{"id":948158,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":7,"price":3.91,"value":27.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701155,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948157,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":8,"price":3.94,"value":31.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701148,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948156,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.01,"value":32.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701140,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948155,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.21,"value":33.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701132,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948154,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.26,"value":34.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701124,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948153,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.13,"value":33.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701116,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948152,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":7,"price":4.32,"value":30.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701108,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948151,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.19,"value":33.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701101,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948150,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":10,"price":4.19,"value":41.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701093,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948149,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":10,"price":3.65,"value":36.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701083,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948148,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":14,"price":3.27,"value":45.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701073,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948147,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.82,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701059,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948146,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.5,"value":35.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701045,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948145,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.56,"value":35.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701031,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948144,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.6,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701017,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948143,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.32,"value":32.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5701003,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948142,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.4,"value":33.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700989,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948141,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.34,"value":42.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700975,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948140,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.27,"value":40.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700957,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948139,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.25,"value":40.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700939,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948138,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.24,"value":40.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700921,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":948137,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T22:03:52.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.36,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700903,"source":{"system":"sec-edgar","filing":"0001087294-26-000004","document":"wk-form4_1767737028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000004/wk-form4_1767737028.xml","form_type":"4"}},{"id":985504,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-28","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.41,"value":43.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700885,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985503,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-26","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.17,"value":39.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700867,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985502,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-25","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.21,"value":39.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700849,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985501,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-24","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.1,"value":37.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700831,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985500,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-21","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.96,"value":33.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700813,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985499,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-20","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.99,"value":33.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700796,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985498,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-19","kind":"other","planned":true,"acquired":true,"shares":17,"price":2.01,"value":34.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700779,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985497,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-18","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.98,"value":33.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700762,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985496,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-17","kind":"other","planned":true,"acquired":true,"shares":17,"price":2.17,"value":36.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700745,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985495,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-14","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.15,"value":34.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700728,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985494,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-13","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.17,"value":34.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700712,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985493,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-12","kind":"other","planned":true,"acquired":true,"shares":16,"price":1.99,"value":31.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700696,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985492,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-11","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.06,"value":32.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700680,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985491,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-10","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.11,"value":33.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700664,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985490,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-07","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.19,"value":28.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700648,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985489,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-06","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.27,"value":29.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700635,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985488,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-05","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.53,"value":32.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700622,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985487,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-04","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.82,"value":36.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700609,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":985486,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-12-01T22:03:24.000Z","date":"2025-11-03","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.8,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700596,"source":{"system":"sec-edgar","filing":"0001087294-25-000027","document":"wk-form4_1764626600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000027/wk-form4_1764626600.xml","form_type":"4"}},{"id":1009944,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-31","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.39,"value":44.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700583,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009943,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-30","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.29,"value":42.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700570,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009942,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-29","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.26,"value":42.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700557,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009941,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-28","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.28,"value":42.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700544,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009940,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-27","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.49,"value":45.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700531,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009939,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-24","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.51,"value":45.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700518,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009938,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-23","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.44,"value":44.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700505,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009937,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-22","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.62,"value":47.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700492,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009936,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-21","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.61,"value":46.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700479,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009935,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-20","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.52,"value":45.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700466,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009934,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-17","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.48,"value":45.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700453,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009933,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-16","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.49,"value":45.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700440,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009932,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-15","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.37,"value":43.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700427,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009931,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-14","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.35,"value":43.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700414,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009930,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-13","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.54,"value":46.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700401,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009929,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-10","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.59,"value":46.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700388,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009928,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-09","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.56,"value":46.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700375,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009927,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-08","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.63,"value":47.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700362,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009926,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-07","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.19,"value":41.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700349,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009925,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-06","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.14,"value":40.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700336,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009924,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-03","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.25,"value":42.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700323,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009923,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-02","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.28,"value":42.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700310,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1009922,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-11-03T12:56:41.000Z","date":"2025-10-01","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.31,"value":43.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700297,"source":{"system":"sec-edgar","filing":"0001075050-25-000006","document":"wk-form4_1762174598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000107505025000006/wk-form4_1762174598.xml","form_type":"4"}},{"id":1025387,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-30","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.12,"value":40.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700284,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025386,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-29","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.14,"value":40.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700271,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025385,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-26","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.05,"value":36.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700258,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025384,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-25","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.1,"value":37.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700246,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025383,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-24","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.1,"value":37.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700234,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025382,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-23","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.21,"value":38.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700222,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025381,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-22","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.29,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700210,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025380,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-19","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.34,"value":40.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700198,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025379,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-18","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.31,"value":39.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700186,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025378,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-17","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.38,"value":40.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700174,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025377,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-16","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.5,"value":42.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700162,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025376,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-15","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.5,"value":42.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700150,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025375,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-12","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.54,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700138,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025374,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-11","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.41,"value":40.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700126,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025373,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-10","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.39,"value":40.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700114,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025372,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-09","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.43,"value":41.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700102,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025371,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-08","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.41,"value":40.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700090,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025370,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-05","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.6,"value":43.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700078,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025369,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-04","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.6,"value":43.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700066,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025368,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-03","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.58,"value":42.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700054,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1025367,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-10-03T20:01:46.000Z","date":"2025-09-02","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.54,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700042,"source":{"system":"sec-edgar","filing":"0001087294-25-000007","document":"wk-form4_1759521702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000007/wk-form4_1759521702.xml","form_type":"4"}},{"id":1042080,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-29","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.45,"value":44.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700030,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042079,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-28","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.47,"value":45.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700017,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042078,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-27","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.44,"value":44.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5700004,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042077,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-26","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.39,"value":44.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699991,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042076,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-25","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.32,"value":43.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699978,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042075,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-22","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.31,"value":43.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699965,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042074,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-21","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.25,"value":42.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699952,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042073,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-20","kind":"purchase","planned":true,"acquired":true,"shares":2,"price":3.15,"value":6.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699939,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042072,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-19","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.23,"value":41.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699937,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042071,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-18","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.11,"value":40.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699924,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042070,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-15","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.02,"value":39.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699911,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042069,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-14","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":2.84,"value":36.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699898,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}},{"id":1042068,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56918,"kind":"person","name":"KAZIMI A J","position":1,"cik":"0001075050","reported_name":"KAZIMI A J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2025-09-12T12:34:18.000Z","date":"2025-08-13","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":2.94,"value":38.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":5699885,"source":{"system":"sec-edgar","filing":"0001628280-25-041985","document":"wk-form4_1757680454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041985/wk-form4_1757680454.xml","form_type":"4"}}],"next_cursor":"2025-09-12T12:34:18.000000Z,1042068"}